Pedal to preserve sight: study tests if exercise slows glaucoma damage
NCT ID NCT05581498
First seen Jun 25, 2026 · Last updated Aug 06, 2026 · Updated 3 times
Summary
This study looks at whether a 12-week home exercise program (cycling and resistance training) can improve vision and quality of life in people with glaucoma. Researchers will measure changes in visual field sensitivity, eye blood flow, and oxygen use. The goal is to see if exercise might protect nerve cells in the eye from further damage.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- exercise (cycling and resistance training)
- What this could lead to
- If it works, this could show that regular exercise helps protect vision and improve daily life for people with glaucoma.
- What could go wrong
- This is a small, early-stage study with only 150 participants. Exercise may not produce meaningful changes in vision, and results may not apply to everyone with glaucoma.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age 21 40 to 80 (for glaucoma and control groups - pilot subjects must be age 21-80) 2. Ability to read and respond to questions in English (facilitating GlauCAT™ questionnaire completion) 3. Physician diagnosis of primary open-angle glaucoma in both eyes (glaucoma group) 4. Visual field mean deviation between -5 and -15 dB (decibel) in at least one eye (glaucoma group) 5. Visual acuity of 20/40 or better in both eyes (control and pilot groups) 6. Normal contrast sensitivity as judged by a logCS\>1.50 in both eyes (control and pilot groups) 7. Willingness to have at least 1 eye dilated at 3 prescribed study visits. Exclusion Criteria: 1. The presence of self-reported or chart-recorded significant comorbid eye conditions in either eye, including diabetic retinopathy, retinal detachment, uveitis, retinal artery or vein occlusion, central serous retinopathy, amblyopia, or optic neuropathy other than glaucoma. 2. Individuals will also be excluded from the control group if they have a history of self-reported or chart-recorded glaucoma, suspect glaucoma, or ocular hypertension. Individuals with less serious conditions (dry eye, early cataract, mild posterior capsular opacification, mild epiretinal membranes, allergic conjunctivitis, pinguecula, etc.) will be allowed into the study if they meet the visual criteria above. 3. Uncontrolled blood pressure (BP), with systolic blood pressure (SBP) BP\>160 or diastolic blood pressure (DBP) BP\>100 at the first study visit (with or without anti-hypertensive medications). 4. Incisional procedures (ocular or non-ocular) in the past 6 months (minor dermatological procedures are acceptable). 5. Self-report of comorbidities or orthopedic issues which would make the prescribed exercise (resistance band training and exercise bicycling) impossible. 6. Current cigarette smoking or using electronic cigarettes to smoke. 7. Body mass index \<18 or \>42 kg/m2. 8. Current or planned pregnancy. 9. Self-report moderate or vigorous activity for more than 90 minutes weekly. Activities classified as moderate/vigorous include running, swimming, resistance training, most sports (basketball, volleyball, tennis), walking briskly (15' per mile), bicycling, active gardening, aerobics, or other similar activities. 10. Suitability for exercise will be confirmed by administering the Physical Activity (PA) Readiness Questionnaire Plus (PAR-Q+), a two-part questionnaire in which individuals can be categorized as fit for exercise. In the first part of the questionnaire, patients are asked 7 questions regarding self-reported: (1) heart disease/high blood pressure, (2) chest pain at rest or with activity, (3) poor balance, dizziness or loss of consciousness, (4) chronic medical conditions other than heart disease, (5) medications for chronic medical conditions, (6) bone or joint problems that could worsen with physical activity, or (7) being told by a doctor that they should only do medically-supervised physical activity. 11. If individuals answer no, they are eligible for the exercise intervention. 12. If they answer yes, they are asked several additional, more detailed questions to gauge the severity of their conditions (i.e., arthritis requiring steroid injections or tablets, cancer requiring active chemotherapy, chronic heart failure, etc.). If they answer yes to any of these questions, they will be excluded from study participation. 13. As some exclusion criteria (blood pressure, body-mass index, PAR-Q+ scores) are obtained after the consent, the numbers consenting and proceeding to the test will differ.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Glaucoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise shield the eyes of glaucoma patients?
- One operation for cataract and glaucoma? eye surgeons test a Two-in-One approach
- Can better Follow-Up schedules save sight in glaucoma?
- Portable devices could take the guesswork out of eye pressure checks
- Eye drops may shield the cornea after cataract surgery
- Can a puff of air replace the eye pressure probe?